Evidence map›Paper›PMID 22940425›Full record

ArticleAntiviral research2012

Fluorescent primuline derivatives inhibit hepatitis C virus NS3-catalyzed RNA unwinding, peptide hydrolysis and viral replicase formation.

Jean Ndjomou, Rajesh Kolli, Sourav Mukherjee, William R Shadrick, Alicia M Hanson, Noreena L Sweeney, Diana Bartczak, Kelin Li, Kevin J Frankowski, Frank J Schoenen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Antiviral research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jean NdjomouDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, 3210 N. Cramer St., Milwaukee, WI 53211, United States.
Rajesh Kolli
Sourav Mukherjee
William R Shadrick
Alicia M Hanson
Noreena L Sweeney
Diana Bartczak
Kelin Li
Kevin J Frankowski
Frank J Schoenen
David N Frick
University of Wisconsin–Milwaukee · USUniversity of Kansas · US

Funding

University of Kansas Specialized Chemistry CenterU54HG005031 · NHGRI · UNIVERSITY OF KANSAS LAWRENCE · PI AUBE, JEFFREY · 2008 to 2013
$21.5M
Antiviral potential of helicase inhibitorsR01AI088001 · NIAID · UNIVERSITY OF WISCONSIN MILWAUKEE · PI FRICK, DAVID N · 2010 to 2012
$1.1M
Hepatitis C VIrus NS3 Helicase Inhibitor DiscoveryR03MH085690 · NIMH · NEW YORK MEDICAL COLLEGE · PI FRICK, DAVID N · 2008 to 2008
$25k
NHGRI NIH HHS U54 HG005031NIAID NIH HHS R01 AI088001NIMH NIH HHS R03 MH085690NIMH NIH HHS R03 MH085690-01
6 · The paper itself

Abstract

The hepatitis C virus (HCV) multifunctional nonstructural protein 3 (NS3) is a protease that cleaves viral and host proteins and a helicase that separates DNA and RNA structures in reactions fueled by ATP hydrolysis. Li et al. (2012) recently synthesized a series of new NS3 helicase inhibitors from the benzothiazole dimer component of the fluorescent yellow dye primuline. This study further characterizes a subset of these primuline derivatives with respect to their specificity, mechanism of action, and effect on cells harboring HCV subgenomic replicons. All compounds inhibited DNA and RNA unwinding catalyzed by NS3 from different HCV genotypes, but only some inhibited the NS3 protease function, and few had any effect on HCV NS3 catalyzed ATP hydrolysis. A different subset contained potent inhibitors of RNA stimulated ATP hydrolysis catalyzed by the related NS3 protein from Dengue virus. In assays monitoring intrinsic protein fluorescence in the absence of nucleic acids, the compounds cooperatively bound NS3 with K(d)s that reflect their potency in assays. The fluorescent properties of the primuline derivatives both in vitro and in cells are also described. The primuline derivative that was the most active against subgenomic replicons in cells caused a 14-fold drop in HCV RNA levels (IC(50)=5±2μM). In cells, the most effective primuline derivative did not inhibit the cellular activity of NS3 protease but disrupted HCV replicase structures.

Indexed as

Antiviral AgentsCell LineDEAD-box RNA HelicasesDNA HelicasesEnzyme InhibitorsFluorescenceHepacivirusHumansInhibitory Concentration 50Microbial Sensitivity TestsNucleoside-TriphosphataseProtein BindingRNA-Dependent RNA PolymeraseSerine EndopeptidasesThiazolesViral Nonstructural ProteinsAntiviral AgentsDEAD-box RNA HelicasesDNA HelicasesEnzyme InhibitorsNS3 protein, hepatitis C virusNucleoside-TriphosphataseprimulineRNA-Dependent RNA PolymeraseSerine EndopeptidasesThiazolesViral Nonstructural ProteinsViral Proteases

Identifiers

PMID22940425
PMCPMC3571690
OpenAlexW2089336801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.